MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series - Ugurel, S; Spassova, I; Wolfahrt, J (Cancer Immunol Immunother, 2019)
et al.